LATEST NEWS AND EVENTS
ECAN Experts cited in US News & World Report
“Esophageal Cancer: What to Know” is a new report from U.S. News & World Report by contributing writer David Levine. […]
FDA Fast-Tracks Review of 3 New Immunotherapy Options for Esophageal Cancer Patients
The U.S. Food & Drug Administration has granted Priority Review for the use of immunotherapies in three new designations for […]
New Treatment Option for Patients with HER2+ Gastroesophageal Junction Adenocarcinoma
The U.S. Food & Drug Administration has approved a new therapy for adult patients with locally advanced or metastatic HER2+ […]
Medical Advances ● Advocacy Campaigns ● Awareness Efforts
We respect your privacy and will never share your information.